Oropharyngeal Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
Conditions:   Oral Squamous Cell Carcinoma;   Oropharyngeal Squamous Cell Carcinoma Interventions:   Drug: Tislelizumab;   Drug: Albumin-Bound Paclitaxel;   Drug: Cisplatin Sponsor:   Peking University Hospital of Stomatology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Therapeutic Vaccine in Patients With Human Papillomavirus HPV-positive Oropharyngeal Cancer
Conditions:   Head and Neck Carcinoma;   Adult Disease Interventions:   Biological: HPVDC injection level dose 1;   Biological: placebo injection level dose 1;   Biological: HPVDC injection level dose 2;   Biological: placebo injection level dose 2 Sponsors:   Gustave Roussy, Cancer Campus, Grand Paris;   LinKinVax Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials